PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+10.06%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.08B
AUM Growth
+$3.08B
(-0.87%)
Cap. Flow
-$95.9M
Cap. Flow
% of AUM
-3.11%
Top 10 Holdings %
Top 10 Hldgs %
37.15%
Holding
94
New
12
Increased
13
Reduced
16
Closed
15
Top Buys
| 1 |
Erasca
ERAS
|
$98.2M |
| 2 |
Caribou Biosciences
CRBU
|
$88.2M |
| 3 |
Cytokinetics
CYTK
|
$52.6M |
| 4 |
SOPHiA GENETICS
SOPH
|
$35.5M |
| 5 |
AstraZeneca
AZN
|
$34.7M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$166M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$68.5M |
| 3 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$43.5M |
| 4 |
Baxter International
BAX
|
$36.9M |
| 5 |
Guardant Health
GH
|
$36.2M |
Sector Composition
| 1 | Healthcare | 94.98% |
| 2 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | -2,807,310 | Closed | -$68.5M |
|
77
Athira Pharma
ATHA
$15.3M
| – | – | -678,247 | Closed | -$6.95M |
|
|
78
Baxter International
BAX
$12.7B
| – | – | -458,667 | Closed | -$36.9M |
|
79
Bristol-Myers Squibb
BMY
$96B
| – | – | 0 | – | – |
|
80
Doximity
DOCS
$12.7B
| – | – | -30,000 | Closed | -$1.75M |
|
81
InnovAge Holding
INNV
$517M
| – | – | -429,699 | Closed | -$9.16M |
|
82
Labcorp
LH
$23.1B
| – | – | -63,640 | Closed | -$17.6M |
|
83
Moderna
MRNA
$9.37B
| – | – | 0 | – | – |
|
84
Shattuck Labs
STTK
$47M
| – | – | -326,813 | Closed | -$9.47M |
|
85
Financial Select Sector SPDR Fund
XLF
$54.1B
| – | – | 0 | – | – |
|
|
OSH
86
DELISTED
Oak Street Health, Inc.
OSH
| – | – | -67,250 | Closed | -$3.94M |
|
|
MYOV
87
DELISTED
Myovant Sciences Ltd.
MYOV
| – | – | -1,912,188 | Closed | -$43.5M |
|
|
ONEM
88
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| – | – | -171,689 | Closed | -$5.68M |
|